SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-126381
Filing Date
2023-12-15
Accepted
2023-12-15 16:01:42
Documents
1
Period of Report
2023-12-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2332964-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2332964-2_4seq1.xml 4 3973
  Complete submission text file 0001104659-23-126381.txt   5669
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Issuer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108
Business Address
Wolf Jeffrey Alan (Reporting) CIK: 0001381450 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12584 | Film No.: 231490201